|
1
|
Derman BA, Mileham KF, Bonomi PD, Batus M
and Fidler MJ: Treatment of advanced squamous cell carcinoma of the
lung: A review. Transl Lung Cancer Res. 4:524–532. 2015.PubMed/NCBI
|
|
2
|
Minami H, Isomoto H, Inoue H, Akazawa Y,
Yamaguchi N, Ohnita K, Takeshima F, Hayashi T, Nakayama T and Nakao
K: Significance of background coloration in endoscopic detection of
early esophageal squamous cell carcinoma. Digestion. 89:6–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weißenborn C, Ignatov T, Ochel HJ, Costa
SD, Zenclussen AC, Ignatova Z and Ignatov A: GPER functions as a
tumor suppressor in triple-negative breast cancer cells. J Cancer
Res Clin Oncol. 140:713–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calì G, Insabato L, Conza D, Bifulco G,
Parrillo L, Mirra P, Fiory F, Miele C, Raciti GA, Di Jeso B, et al:
GRP78 mediates cell growth and invasiveness in endometrial cancer.
J Cell Physiol. 229:1417–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan B, Anaka M, Deb S, Freyer C, Ebert LM,
Chueh AC, Al-Obaidi S, Behren A, Jayachandran A, Cebon J, et al:
FOXP3 over-expression inhibits melanoma tumorigenesis via effects
on proliferation and apoptosis. Oncotarget. 5:264–276.
2014.PubMed/NCBI
|
|
6
|
Correa TC, Brohem CA, Winnischofer SM, da
Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC and
Maria-Engler SS: Downregulation of the RECK-tumor and metastasis
suppressor gene in glioma invasiveness. J Cell Biochem. 99:156–167.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Romagnolo AP, Romagnolo DF and Selmin OI:
BRCA1 as target for breast cancer prevention and therapy.
Anticancer Agents Med Chem. 15:4–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thaler S, Hähnel PS, Schad A, Dammann R
and Schuler M: RASSF1A mediates p21Cip1/Waf1-dependent cell cycle
arrest and senescence through modulation of the Raf-MEK-ERK pathway
and inhibition of Akt. Cancer Res. 69:1748–1757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Ge J, Ma T, Zheng Y, Lv S, Li Y
and Liu S: Promoter hypermethylation of the cysteine protease RECK
may cause metastasis of osteosarcoma. Tumour Biol. 36:9511–9516.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Magdinier F, Ribieras S, Lenoir GM,
Frappart L and Dante R: Down-regulation of BRCA1 in human sporadic
breast cancer; analysis of DNA methylation patterns of the putative
promoter region. Oncogene. 17:3169–3176. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dammann R, Schagdarsurengin U, Strunnikova
M, Rastetter M, Seidel C, Liu L, Tommasi S and Pfeifer GP:
Epigenetic inactivation of the Ras-association domain family 1
(RASSF1A) gene and its function in human carcinogenesis. Histol
Histopathol. 18:665–677. 2003.PubMed/NCBI
|
|
12
|
Wiggins RC, Wiggins JE, Goyal M, Wharram
BL and Thomas PE: Molecular cloning of cDNAs encoding human GLEPP1,
a membrane protein tyrosine phosphatase: Characterization of the
GLEPP1 protein distribution in human kidney and assignment of the
GLEPP1 gene to human chromosome 12p12-p13. Genomics. 27:174–181.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Motiwala T, Ghoshal K, Das A, Majumder S,
Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST and Plass C:
Suppression of the protein tyrosine phosphatase receptor type O
gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene.
22:6319–6331. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Motiwala T, Kutay H, Ghoshal K, Bai S,
Seimiya H, Tsuruo T, Suster S, Morrison C and Jacob ST: Protein
tyrosine phosphatase receptor-type O (PTPRO) exhibits
characteristics of a candidate tumor suppressor in human lung
cancer. Proc Natl Acad Sci USA. 101:13844–13849. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Motiwala T, Majumder S, Kutay H, Smith DS,
Neuberg DS, Lucas DM, Byrd JC, Grever M and Jacob ST: Methylation
and silencing of protein tyrosine phosphatase receptor type O in
chronic lymphocytic leukemia. Clin Cancer Res. 13:3174–3181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
You YJ, Chen YP, Zheng XX, Meltzer SJ and
Zhang H: Aberrant methylation of the PTPRO gene in peripheral blood
as a potential biomarker in esophageal squamous cell carcinoma
patients. Cancer Lett. 315:138–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laczmanska I and Sasiadek MM: Tyrosine
phosphatases as a superfamily of tumor suppressors in colorectal
cancer. Acta Biochim Pol. 58:467–470. 2011.PubMed/NCBI
|
|
18
|
Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng
L, Huang X, Wang X and Sun B: Estrogen-sensitive PTPRO expression
represses hepatocellular carcinoma progression by control of STAT3.
Hepatology. 57:678–688. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen L, Juszczynski P, Takeyama K, Aguiar
RC and Shipp MA: Protein tyrosine phosphatase receptor-type O
truncated (PTPROt) regulates SYK phosphorylation, proximal
B-cell-receptor signaling and cellular proliferation. Blood.
108:3428–3433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Hou J, Ren L, He J, Sun B, Sun LZ
and Wang S: Protein tyrosine phosphatase receptor type O expression
in the tumor niche correlates with reduced tumor growth,
angiogenesis, circulating tumor cells and metastasis of breast
cancer. Oncol Rep. 33:1908–1914. 2015.PubMed/NCBI
|
|
21
|
Yu M, Lin G, Arshadi N, Kalatskaya I, Xue
B, Haider S, Nguyen F, Boutros PC, Elson A, Muthuswamy LB, et al:
Expression profiling during mammary epithelial cell
three-dimensional morphogenesis identifies PTPRO as a novel
regulator of morphogenesis and ErbB2-mediated transformation. Mol
Cell Biol. 32:3913–3924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chien W, Yin D, Gui D, Mori A, Frank JM,
Said J, Kusuanco D, Marchevsky A, McKenna R and Koeffler HP:
Suppression of cell proliferation and signaling transduction by
connective tissue growth factor in non-small cell lung cancer
cells. Mol Cancer Res. 4:591–598. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Werstuck GH, Lentz SR, Dayal S, Hossain
GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR and
Austin RC: Homocysteine-induced endoplasmic reticulum stress causes
dysregulation of the cholesterol and triglyceride biosynthetic
pathways. J Clin Invest. 107:1263–1273. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jerónimo C, Henrique R, Hoque MO, Ribeiro
FR, Oliveira J, Fonseca D, Teixeira MR, Lopes C and Sidransky D:
Quantitative RARbeta2 hypermethylation: A promising prostate cancer
marker. Clin Cancer Res. 10:4010–4014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coutinho-Camillo CM, Lourenço SV, de
Araújo Lima L, Kowalski LP and Soares FA: Expression of
apoptosis-regulating miRNAs and target mRNAs in oral squamous cell
carcinoma. Cancer Genet. 208:382–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Xu Y, He C, Guo X, Zhang J, He C,
Zhang L, Kong M, Chen B and Zhu C: Elevated expression of CCAT2 is
associated with poor prognosis in esophageal squamous cell
carcinoma. J Surg Oncol. 111:834–839. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jacob ST and Motiwala T: Epigenetic
regulation of protein tyrosine phosphatases: Potential molecular
targets for cancer therapy. Cancer Gene Ther. 12:665–672. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matozaki T and Kasuga M: Roles of
protein-tyrosine phosphatases in growth factor signalling. Cell
Signal. 8:13–19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li SY, Li R, Chen YL, Xiong LK, Wang HL,
Rong L and Luo RC: Aberrant PTPRO methylation in tumor tissues as a
potential biomarker that predicts clinical outcomes in breast
cancer patients. BMC Genet. 15:672014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Asbagh LA, Vazquez I, Vecchione L,
Budinska E, De Vriendt V, Baietti MF, Steklov M, Jacobs B, Hoe N,
Singh S, et al: The tyrosine phosphatase PTPRO sensitizes colon
cancer cells to anti-EGFR therapy through activation of
SRC-mediated EGFR signaling. Oncotarget. 5:10070–10083. 2014.
View Article : Google Scholar : PubMed/NCBI
|
